Citadel Advisors’s Precision BioSciences DTIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-153,675
Closed -$586K 6155
2024
Q4
$586K Buy
153,675
+56,400
+58% +$215K ﹤0.01% 3833
2024
Q3
$872K Hold
97,275
﹤0.01% 3234
2024
Q2
$946K Hold
97,275
﹤0.01% 3093
2024
Q1
$1.32M Sell
97,275
-18,250
-16% -$247K ﹤0.01% 2897
2023
Q4
$1.27M Buy
115,525
+11,061
+11% +$121K ﹤0.01% 2813
2023
Q3
$1.07M Buy
104,464
+14,063
+16% +$144K ﹤0.01% 2984
2023
Q2
$1.43M Sell
90,401
-4,179
-4% -$65.9K ﹤0.01% 2695
2023
Q1
$2.14M Buy
94,580
+28,879
+44% +$653K ﹤0.01% 2476
2022
Q4
$2.35M Buy
65,701
+7,217
+12% +$258K ﹤0.01% 2431
2022
Q3
$2.28M Buy
58,484
+11,101
+23% +$433K ﹤0.01% 2609
2022
Q2
$2.27M Buy
47,383
+34,198
+259% +$1.64M ﹤0.01% 2614
2022
Q1
$1.22M Buy
13,185
+11,480
+673% +$1.06M ﹤0.01% 3552
2021
Q4
$379K Sell
1,705
-4,943
-74% -$1.1M ﹤0.01% 4880
2021
Q3
$2.3M Buy
6,648
+3,560
+115% +$1.23M ﹤0.01% 2841
2021
Q2
$1.16M Sell
3,088
-4,556
-60% -$1.71M ﹤0.01% 3827
2021
Q1
$2.37M Sell
7,644
-42,582
-85% -$13.2M ﹤0.01% 2968
2020
Q4
$12.6M Buy
50,226
+48,200
+2,379% +$12.1M ﹤0.01% 1128
2020
Q3
$374K Buy
2,026
+364
+22% +$67.2K ﹤0.01% 3703
2020
Q2
$415K Sell
1,662
-3,558
-68% -$888K ﹤0.01% 3582
2020
Q1
$945K Sell
5,220
-2,626
-33% -$475K ﹤0.01% 2923
2019
Q4
$3.27M Buy
7,846
+6,785
+639% +$2.83M ﹤0.01% 1945
2019
Q3
$267K Sell
1,061
-1,269
-54% -$319K ﹤0.01% 3936
2019
Q2
$926K Buy
2,330
+720
+45% +$286K ﹤0.01% 3039
2019
Q1
$867K Buy
+1,610
New +$867K ﹤0.01% 2952